257 related articles for article (PubMed ID: 25663279)
1. Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion.
Keeratichananont W; Limthon T; Keeratichananont S
Ther Adv Respir Dis; 2015 Apr; 9(2):42-8. PubMed ID: 25663279
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.
Keeratichananont W; Kaewdech A; Keeratichananont S
Ther Adv Respir Dis; 2018; 12():1753466618816625. PubMed ID: 30526440
[TBL] [Abstract][Full Text] [Related]
3. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
4. Is silver nitrate an effective means of pleurodesis?
Bucknor A; Harrison-Phipps K; Davies T; Toufektzian L
Interact Cardiovasc Thorac Surg; 2015 Oct; 21(4):521-5. PubMed ID: 26188199
[TBL] [Abstract][Full Text] [Related]
5. Management of recurrent malignant pleural effusion with chemical pleurodesis.
Kilic D; Akay H; Kavukçu S; Kutlay H; Cangir AK; Enön S; Kadilar C
Surg Today; 2005; 35(8):634-8. PubMed ID: 16034542
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
Neto JD; de Oliveira SF; Vianna SP; Terra RM
Respirology; 2010 Jan; 15(1):115-8. PubMed ID: 19947987
[TBL] [Abstract][Full Text] [Related]
7. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
8. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube.
Caglayan B; Torun E; Turan D; Fidan A; Gemici C; Sarac G; Salepci B; Kiral N
Ann Surg Oncol; 2008 Sep; 15(9):2594-9. PubMed ID: 18594928
[TBL] [Abstract][Full Text] [Related]
10. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
11. Talc pleurodesis in pleuropulmonary diseases treatment.
Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
[TBL] [Abstract][Full Text] [Related]
12. Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
Omoregbee BI; Okugbo S
Pan Afr Med J; 2021; 38():169. PubMed ID: 33995776
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
14. Silver nitrate versus tetracycline in pleurodesis for malignant pleural effusions; a prospective randomized trial.
Tabatabaei SA; Hashemi SM; Kamali A
Adv Biomed Res; 2015; 4():178. PubMed ID: 26605217
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
16. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
17. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin.
Martínez-Moragón E; Aparicio J; Rogado MC; Sanchis J; Sanchis F; Gil-Suay V
Eur Respir J; 1997 Oct; 10(10):2380-3. PubMed ID: 9387969
[TBL] [Abstract][Full Text] [Related]
18. Safety Profile of the Use of Iodopovidone for Pleurodesis in Patients with Malignant Pleural Effusion.
Andrade Neto JD; Terra RM; Teixeira RM; Pereira SV; Pego-Fernandes PM
Respiration; 2015; 90(5):369-75. PubMed ID: 26439936
[TBL] [Abstract][Full Text] [Related]
19. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
20. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
